FilingReader Intelligence

Taiko Pharmaceutical boosts 2025 profit forecast 50% after subsidiary liquidation

August 20, 2025 at 12:06 PM UTCBy FilingReader AI

Taiko Pharmaceutical completed liquidation of its Shanghai subsidiary on August 11, generating a 142 million yen special gain from foreign currency translation adjustments.

The company revised its 2025 net income forecast upward by 50% to 450 million yen. Sales and operating profit forecasts remain unchanged.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Taiko Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →